|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depression | |||||
| Healthy | |||||
| Osteopenia | |||||
| Osteoporosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bone Diseases, Metabolic | |||||
| Depressive Disorder | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| Bone Diseases | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| Musculoskeletal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Alendronate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||